Abstract
The influence of long-term ceftriaxone administration on the emergence of Clostridium difficile was studied with 80 patients receiving ceftriaxone for 14 days. In five patients (6.3%) C. difficile was cultured. The appearance of gastrointestinal disturbances during treatment with ceftriaxone was common, but the rate of emergence of C. difficile in immunocompetent patients was not high.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dattwyler R. J., Halperin J. J., Volkman D. J., Luft B. J. Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin. Lancet. 1988 May 28;1(8596):1191–1194. doi: 10.1016/s0140-6736(88)92011-9. [DOI] [PubMed] [Google Scholar]
- Delmée M., Vandercam B., Avesani V., Michaux J. L. Epidemiology and prevention of Clostridium difficile infections in a leukemia unit. Eur J Clin Microbiol. 1987 Dec;6(6):623–627. doi: 10.1007/BF02013056. [DOI] [PubMed] [Google Scholar]
- George W. L., Sutter V. L., Citron D., Finegold S. M. Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol. 1979 Feb;9(2):214–219. doi: 10.1128/jcm.9.2.214-219.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johnson S., Clabots C. R., Linn F. V., Olson M. M., Peterson L. R., Gerding D. N. Nosocomial Clostridium difficile colonisation and disease. Lancet. 1990 Jul 14;336(8707):97–100. doi: 10.1016/0140-6736(90)91605-a. [DOI] [PubMed] [Google Scholar]
- McFarland L. V., Stamm W. E. Review of Clostridium difficile-associated diseases. Am J Infect Control. 1986 Jun;14(3):99–109. doi: 10.1016/0196-6553(86)90018-0. [DOI] [PubMed] [Google Scholar]
- McFarland L. V., Surawicz C. M., Stamm W. E. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis. 1990 Sep;162(3):678–684. doi: 10.1093/infdis/162.3.678. [DOI] [PubMed] [Google Scholar]
- Nahata M. C., Miller M. A. Diarrhoea associated with ceftriaxone and its implications in paediatric patients. J Clin Pharm Ther. 1989 Aug;14(4):305–307. doi: 10.1111/j.1365-2710.1989.tb00251.x. [DOI] [PubMed] [Google Scholar]
- Privitera G., Scarpellini P., Ortisi G., Nicastro G., Nicolin R., de Lalla F. Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery. Antimicrob Agents Chemother. 1991 Jan;35(1):208–210. doi: 10.1128/aac.35.1.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steere A. C. Lyme disease. N Engl J Med. 1989 Aug 31;321(9):586–596. doi: 10.1056/NEJM198908313210906. [DOI] [PubMed] [Google Scholar]
- Thibault A., Miller M. A., Gaese C. Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol. 1991 Jun;12(6):345–348. doi: 10.1086/646354. [DOI] [PubMed] [Google Scholar]
- Willey S. H., Bartlett J. G. Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin. J Clin Microbiol. 1979 Dec;10(6):880–884. doi: 10.1128/jcm.10.6.880-884.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilson K. H., Kennedy M. J., Fekety F. R. Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J Clin Microbiol. 1982 Mar;15(3):443–446. doi: 10.1128/jcm.15.3.443-446.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- de Lalla F., Privitera G., Ortisi G., Rizzardini G., Santoro D., Pagano A., Rinaldi E., Scarpellini P. Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: a four-year survey in a general hospital. J Antimicrob Chemother. 1989 Apr;23(4):623–631. doi: 10.1093/jac/23.4.623. [DOI] [PubMed] [Google Scholar]